You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
199-biotechnologies
Digital health portfolio advancing medical research through exponential technology. Part of 199 Group.
Proactive context synthesis for coding agents. Build the right context before the first token.
About
199 Biotechnologies (SG) Pte Ltd is a Singapore-based longevity and AI company. We build open-source developer tools, agent infrastructure, and biotech research platforms.
Paperfoot AI is our AI research lab, focused on agent-native tooling, on-device inference, and cross-model orchestration.
Boris Djordjevic — Founder
Serial entrepreneur and technologist based in Singapore. Background spans biotech, fintech, and consumer tech across the UK, Serbia, and Southeast Asia. Obsessed with longevity science and building tools that let AI agents do real work — not just chat. Ships Rust CLIs, iOS apps, and ML pipelines. Believes the best code is the code you delete.
Previously founded companies in digital health, forex trading, and creative technology. Now focused full-time on making the 200-year lifespan an engineering problem rather than a philosophical one.
Enterprise-grade deep research skill for Claude Code with 8-phase pipeline, source credibility scoring, and automated validation. Outperforms OpenAI, Gemini, and Claude Desktop in quality and verif…
Production-ready Claude skill for comprehensive SEO/GEO optimization. Analyzes content for traditional search engines + AI platforms (ChatGPT, Perplexity, Claude, Gemini). Includes entity extractio…